TheraRadar
← Back
Data updated: Mar 29, 2026

BIOFRONTERA

OncologyDermatology
Pharma

BIOFRONTERA is a pharmaceutical company focused on Oncology, Dermatology. Key products include AMELUZ.

2000
Since
2
Drugs
-
Trials
1
Approved (2yr)

Key Drugs

AMELUZ
aminolevulinic acid hydrochloride
protoporphyrin IX 1 indications · 2016

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

AMELUZ 2024-10-04
Efficacy
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 67%
0 drugs Phase 3: 1
Dermatology 33%
0 drugs Phase 2: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Dermatology
Baxter specialty
Oncology, Dermatology
Eli Lilly big-pharma
Oncology, Dermatology
Bayer big-pharma
Oncology, Dermatology
COSETTE other
Dermatology, Oncology